Edbi Pte LTD I Mab Transaction History
Edbi Pte LTD
- $94.4 Million
- Q4 2024
A detailed history of Edbi Pte LTD transactions in I Mab stock. As of the latest transaction made, Edbi Pte LTD holds 222,136 shares of IMAB stock, worth $559,782. This represents 0.2% of its overall portfolio holdings.
Number of Shares
222,136
Previous 222,136
-0.0%
Holding current value
$559,782
Previous $275,000
31.64%
% of portfolio
0.2%
Previous 0.37%
Shares
1 transactions
Others Institutions Holding IMAB
# of Institutions
38Shares Held
13.8MCall Options Held
20KPut Options Held
13.3K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$15.1 Million0.15% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$10.5 Million3.04% of portfolio
-
Sg Americas Securities, LLC822KShares$2.07 Million0.0% of portfolio
-
Stonepine Capital Management, LLC Bend, OR484KShares$1.22 Million0.39% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny363KShares$915,2640.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $209M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...